The new upgraded version of the current XEVMPD/Article 57 user interface (known as 'EVWEB-Art 57/XEVMPD') is now available to external users, i.e. marketing authorisation holders, sponsors and national competent authorities.Date: 11/02/2026
Access XEVMPDweb
The direct links to the upgraded version (called 'XEVMPDweb') of the XEVMPD production and test environment (XCOMP) are as follows:
XEVMPD production environment: https://eudravigilance-xevmpd.ema.europa.eu/
XEVMPD XCOMP (test) environment: https://eudravigilance-xevmpd-xcomp.ema.europa.eu/
To access the above-mentioned environments, please use your existing credentials.
'XEVMPDweb' is a modern browser-based solution that no longer requires the installation of additional components (ActiveX and/or IE Tab), while maintaining a similar look and feel and preserving existing functionalities. However, please note that ActiveX is still required for the use of the Bulk Export Tool and the Bulk Update tool available in the EudraVigilance Restricted area.
Transition period
The current EVWEB-Art 57/XEVMPD user interface continues to be available for use until 10 May 2026; from thereafter, external XEVMPD users will be required to access XEVMPD via XEVMPDweb only.
Further information related to the upgraded user interface is available in the latest version of the Q&A Article KB0014045 in ServiceNow.
Support & engagement opportunities
Access issues or technical issues: please submit a 'Report an Issue' ticket via the EMA Service Desk:
In 'Service' please specify: 'SPOR'
In the 'Service Offering' please specify: ‘XEVMPDweb’ for issues related to the upgraded interface, ‘XEVMPD/Art.57’ for issues related to the current interface
Questions related to the new upgraded XEVMPD user interface (XEVMPDweb): please submit a 'Request for Information' ticket via the EMA Service Desk:
In 'Service' please specify: 'SPOR'
In the 'Service Offering' please specify: XEVMPDweb
Live engagement opportunities: EMA will continue to support users through the existing live engagement channels, including monthly XEVMPD Q&A Clinics and the quarterly SPOR & XEVMPD status update webinars.